G6PD and malaria: This suggests that AEOGL had an antioxidant impact when co-administered with primaquine and could be a candidate for the development of an antimalarial-medicinal plant combination regimen to treat malaria especially in sickle cell and G6PD-deficient patients prone to oxidative stress.